O&G · Antenatal care — maternal medicine
Gestational diabetes: screening, diagnosis, management
Also known as GDM · Gestational diabetes mellitus · Hyperglycaemia in pregnancy · Glucose intolerance of pregnancy · Pregnancy oral glucose tolerance test · POGTT
Exam-exhaustive FRANZCOG fellowship reference on gestational diabetes — the ADIPS 2025 diagnostic thresholds and the screening controversy behind them, HAPO, GEMS, TARGET, TOBOGM and ScreenR2GDM, medical nutrition therapy, metformin and insulin with doses, fetal surveillance, timing and mode of birth, intrapartum glycaemic control, neonatal hypoglycaemia and the postpartum OGTT. RANZCOG-primary, globally tagged to MRCOG and ABOG.
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- First-trimester HbA1c at or above 6.5 percent (48 mmol/mol) — that is overt diabetes in pregnancy, not GDM, and it changes everything you do
- Ketones in a woman labelled with GDM — think undiagnosed type 1 diabetes and exclude ketoacidosis before you reach for the diet sheet
- Accelerating abdominal circumference on serial growth scans despite in-range diaries — believe the fetus, not the logbook
- A GDM diagnosis with no dietitian, no interpreter and no glucose strips is a label, not a treatment
- Polyhydramnios with a large-for-dates fetus — re-test glucose even if the 24–28 week POGTT was normal
- The forgotten postpartum oral glucose tolerance test — one in ten of these women already has type 2 diabetes
It is Tuesday clinic and the GP has sent a 33-year-old at 26 weeks with a fasting glucose of 5.4 mmol/L. Two years ago that number was normal; today it is a diagnosis. Nothing about her has changed — the threshold has. That single sentence is the whole examinable tension in this topic, and the candidate who can argue it from both sides walks out of the station with marks.[1][7]
Overview and definition
Gestational diabetes is a statement about detection, not about aetiology. It means hyperglycaemia first found in pregnancy that does not reach the criteria for overt diabetes.[1][16]
- Some of these women have transient pregnancy-induced glucose intolerance that resolves at birth.
- Some have pre-existing beta-cell dysfunction that pregnancy has simply unmasked.
- A few have undiagnosed type 2 diabetes, monogenic diabetes, or early type 1 diabetes wearing a GDM label.[1][16]
That heterogeneity is why the postpartum test matters as much as the antenatal one, and why "her GDM resolved" is never a discharge diagnosis until you have proved it.[1][15]
References20ShowHide
- [1]Sweeting A, Hare MJ, de Jersey SJ, et al. Australasian Diabetes in Pregnancy Society (ADIPS) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes. Med J Aust, 2025.PMID 40544364
- [2]Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med, 2008.PMID 18463375
- [3]Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care, 2010.PMID 20190296
- [4]Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med, 2005.PMID 15951574
- [5]Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med, 2009.PMID 19797280
- [6]Simmons D, Immanuel J, Hague WM, et al. Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy. N Engl J Med, 2023.PMID 37144983
- [7]Crowther CA, Samuel D, McCowan LME, et al. Lower versus Higher Glycemic Criteria for Diagnosis of Gestational Diabetes. N Engl J Med, 2022.PMID 36070709
- [8]Crowther CA, Samuel D, Hughes R, et al. Tighter or less tight glycaemic targets for women with gestational diabetes mellitus for reducing maternal and perinatal morbidity: A stepped-wedge, cluster-randomised trial. PLoS Med, 2022.PMID 36074760
- [9]Hillier TA, Pedula KL, Ogasawara KK, et al. A Pragmatic, Randomized Clinical Trial of Gestational Diabetes Screening. N Engl J Med, 2021.PMID 33704936
- [10]Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med, 2008.PMID 18463376
- [11]Brown J, Martis R, Hughes B, et al. Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes. Cochrane Database Syst Rev, 2017.PMID 28120427
- [12]Brown J, Alwan NA, West J, et al. Lifestyle interventions for the treatment of women with gestational diabetes. Cochrane Database Syst Rev, 2017.PMID 28472859
- [13]Biesty LM, Egan AM, Dunne F, et al. Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants. Cochrane Database Syst Rev, 2018.PMID 29303230
- [14]Committee on Practice Bulletins-Obstetrics ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol, 2018.PMID 29370047
- [15]Vounzoulaki E, Khunti K, Abner SC, et al. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ, 2020.PMID 32404325
- [16]Sweeting A, Hannah W, Backman H, et al. Epidemiology and management of gestational diabetes. Lancet, 2024.PMID 38909620
- [17]Harris DL, Weston PJ, Harding JE Incidence of neonatal hypoglycemia in babies identified as at risk. J Pediatr, 2012.PMID 22727868
- [18]Roberts L, Lin L, Alsweiler J, et al. Oral dextrose gel to prevent hypoglycaemia in at-risk neonates. Cochrane Database Syst Rev, 2023.PMID 38014716
- [19]Farrant MT, Williamson K, Battin M, et al. The use of dextrose/insulin infusions during labour and delivery in women with gestational diabetes mellitus: Is there any point? Aust N Z J Obstet Gynaecol, 2017.PMID 27531282
- [20]Gordon HG, Shub A, Walker SP, et al. Maternal Diabetes, Fetal Growth, and Stillbirth Risk: A Population-Wide Retrospective Cohort Study From Victoria, Australia. Diabetes Care, 2025.PMID 40902109